Effect of aroma of Rosa damascena Mill in treatment of sleep disorder of patients with cancer

Comparison of aromatherapy with Rosa damascena Mill 5% and 10% on improving sleep quality in patients with sleep disorders (A clinical trial)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017070422865N2

Enrollment

Registered

2017-09-29

Start date

2016-09-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders. Sleep disorders

Interventions

Intervention 1: inhaling 5 drops of essential oil of Rosa damascene 5% (producted in Rayehedarman Company) for two weeks before sleeping. Intervention 2: inhaling 5 drops of essential oil of Rosa dama

Treatment - Drugs

inhaling 5 drops of essential oil of Rosa damascene 5% (producted in Rayehedarman Company) for two weeks before sleeping

inhaling 5 drops of essential oil of Rosa damascene 10% (producted in Rayehedarman Company) for two weeks before sleeping

Observing control group without intervention

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion criteria:"patients with cancer with sleep disorder age 18 to 60 years old; survival>6 months" exclusion criteria:"side effects; trend to leave the study; history of allergy, cough, dyspnea, asthma; smelling disorder; survival<6 months"

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Sleep latency. Timepoint: Before intrvention, Two weeks after intervention. Method of measurement: Pistburg questionaire.;Time of sleeping. Timepoint: Before intervention, Two weeks after intervention. Method of measurement: Pitsburg questionaire.;Time of waking up. Timepoint: at the first & in the end of the intervention. Method of measurement: hour.;Nightmare. Timepoint: Before intervention, Two weeks after intervention. Method of measurement: Pitsburg questionaire.;Wake up during night. Timepoint: Before intervention, Two weeks after intervention. Method of measurement: Pitsburg questionaire.	—

Measure

Time frame

Sleep latency. Timepoint: Before intrvention, Two weeks after intervention. Method of measurement: Pistburg questionaire.;Time of sleeping. Timepoint: Before intervention, Two weeks after intervention. Method of measurement: Pitsburg questionaire.;Time of waking up. Timepoint: at the first & in the end of the intervention. Method of measurement: hour.;Nightmare. Timepoint: Before intervention, Two weeks after intervention. Method of measurement: Pitsburg questionaire.;Wake up during night. Timepoint: Before intervention, Two weeks after intervention. Method of measurement: Pitsburg questionaire.

—

Secondary

Measure	Time frame
Headache. Timepoint: Before intervention, Two weeks after intervention. Method of measurement: File of patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArmaghan Sadat Keyhanmehr

School of Traditinal Medicine , Shahid Beheshti University of Medical Sciences

keyhanmehr@sbmu.ac.ir+98 218877321

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026